Unlocking the full potential of complement therapeutics through the power of selectivity.
2 - 10
💰 $100M Private Equity Round on 2022-04
August 31
🏡 Remote – New York
⏰ Full Time
🟠 Senior
⚙️ Operations
July 26
🔴 Lead
July 25